Likarda is a biotech company developing cell therapies and enabling technologies to transform the way cell therapies are delivered and function. Likarda's foundational technology is based on cell encapsulation and delivery in hydrogels using our patented CSS(tm) (Core-Shell Spherification) system, which is a whole new modality for the delivery of cell therapies. There are no one-size-fits-all solutions, because every cell therapy is unique. Unlike technologies that utilize alginate or modify alginate (which is basically a bandaid to a temporary solution), Likarda utilizes readily available and biocompatible hydrogel materials such Hyaluronic Acid, PEG, and a number of other chemistries to create microcapsules that can easily house cell-based therapies.